Optic nerve diseases and regeneration: How far are we from the promised land?
- PMID: 37317890
- PMCID: PMC10519420
- DOI: 10.1111/ceo.14259
Optic nerve diseases and regeneration: How far are we from the promised land?
Abstract
The retinal ganglion cells (RGCs) are the sole output neurons that connect information from the retina to the brain. Optic neuropathies such as glaucoma, trauma, inflammation, ischemia and hereditary optic neuropathy can cause RGC loss and axon damage, and lead to partial or total loss of vision, which is an irreversible process in mammals. The accurate diagnoses of optic neuropathies are crucial for timely treatments to prevent irrevocable RGCs loss. After severe ON damage in optic neuropathies, promoting RGC axon regeneration is vital for restoring vision. Clearance of neuronal debris, decreased intrinsic growth capacity, and the presence of inhibitory factors have been shown to contribute to the failure of post-traumatic CNS regeneration. Here, we review the current understanding of manifestations and treatments of various common optic neuropathies. We also summarise the current known mechanisms of RGC survival and axon regeneration in mammals, including specific intrinsic signalling pathways, key transcription factors, reprogramming genes, inflammation-related regeneration factors, stem cell therapy, and combination therapies. Significant differences in RGC subtypes in survival and regenerative capacity after injury have also been found. Finally, we highlight the developmental states and non-mammalian species that are capable of regenerating RGC axons after injury, and cellular state reprogramming for neural repair.
Keywords: axon regeneration; optic nerve injury; optic neuropathies; retinal ganglion cells; survival.
© 2023 Royal Australian and New Zealand College of Ophthalmologists.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
The authors declare no conflict of interest.
Comment in
-
Neuronal regeneration in the mammalian central nervous system.Clin Exp Ophthalmol. 2023 Aug;51(6):514-515. doi: 10.1111/ceo.14278. Clin Exp Ophthalmol. 2023. PMID: 37580973 No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
